NASDAQ
Dr. Reddy's Laboratories Limited (RDY) has a eps (diluted) of $53.92 as of Tuesday, March 31, 2026. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.